ArticleESMO gastrointestinal oncology2025

Temporal dynamics of CLDN18.2 expression following zolbetuximab treatment in advanced gastric cancer.

K Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.